Fidelity gets in on $100M round for gene therapy startup Generation Bio – Boston Business Journal
Boston Business Journal |
Fidelity gets in on $100M round for gene therapy startup Generation Bio
Boston Business Journal … 2016, supplying the entire $25 million that made up its Series A round, although the company did not announce its launch until Jan. 4 of this year. Like a handful of other biotech startups locally, Generation Bio is focused on gene therapies, which … Generation Bio Announces $100 Million Series B Financing to Advance GeneWave™ Platform for Re-Dosable Gene … |
